Introduction : Carcinoembryonic antigen is the most commonly used tumour associated antigen in the management of patients with colorectal carcinoma. The test appears useful to determine prognosis and to monitor patients with colorectal carcinoma for early recurrence, persistent elevation of CEA for a month after operation suggests the presence of occult metastatic disease.
Introduction
Carcinoembryonic antigen (CEA) is an oncofetal antigen first described by Gold and Freedom in 19651. Carcinoembryonic antigen is the most commonly used tumour associated antigen in the management of patients with colorectal carcinoma 1 . The sensitivity of CEA as a monitoring test varies from 43% to 89% with a specificity of 70% to 90%. Elevation of CEA in primary tumour correlates with Dukes stage (45% of C tumour and 25% B tumour). However , the test appears useful when used to determine prognosis and to monitor patients with resectable colorectal carcinoma In colon cancer, elevation of serum CEA has been found to be related to the mass of tumour present 3 • The tests appears useful when used to determine prognosis and to monitor patients with resectable colorectal carcinoma for early recurrence 4 • There is significant relationship of serum CEA level and different stage of colorectal carcinoma 5 • CEA is a classical tumour marker for colorectal cancer detected in 1965 by Gold and Freedman 6 . CEA utility regarding colorectal carcinoma has been documented not only for monitoring the recurrence but also during follow up of chemotherapy and as a prognostic factor compared with colonoscopy6, CEA measurement were found to be the most cost effective test in detecting potentially curable recurrent disease.
Materials and Methods
The study involved both cross-sectional and cohort study conducted at the department of Surgical Oncology, National Institute of Cancer Research and Hospital (NICR&H), Dhaka, Bangladesh during the period of January 2010 to June 2012. The study was undertaken among patients with colorectal carcinoma who underwent surgical treatment during the study period. Inclusion criteria were histologically or cytologically diagnosed case of colorectal carcinoma. Exclusion criteria were patients refused to take part in the study and patient already received chemotherapy or radiotherapy. The variable of interest in this study were level of serum CEA in pre and postoperative colorectal cancer patient, Duke stage. Total sample size was 97. Patients of colorectal carcinoma who have proven cytological or histological evidence of malignancy were evaluated clinically. Pre operative serum CEA level was measured then operative management carried out. Post operative CEA was measured before giving chemotherapy within 15th post operative day to 45st post operative day. CEA level was measured from patients' venous blood by ELISA method. Duke staging was confirmed from gross and nodal status from histological report. All the collected information (from the examination findings, available relevant investigations and operation notes) was recorded in a preformed questionnaire. Data from the study were compiled and analyzed using SPSS version 13. Pre and post operative mean CEA levels were compared and paired t-test was used to detect any significant difference. Proportion of elevated levels of CEA was also compared between different tumor stage of the disease, and Chi-squared tests was performed to find any significant difference. Informed written consent from the patients and ethical clearance from authorized persons of our institute was taken before starting of any study procedures. 
Observation and Results
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Among the 97 cases of this study irrespectable of all stages S. CEA was raised in 48% of cases. This study shows that S.CEA level raised with the advanced stage of the disease, Such ~s it was highest in stage D (100%), followed by stage C (67%) & stage B (23%). Statistically it also shows highly significant in Chi-square test where the P value is <. 001.ln my study it was shown that mean post operative CEA level is significantly reduced than that of preoperative level.
Conclusion
The serum CEA level in relation to stage has been proved highly significant in Chi-square test. So it can be concluded that S. CEA level is significantly higher in advanced stages of carcinoma with or without metastasis and lower in early stages. Conclusively it can be said that S. CEA level could play an important role to determine the diagnosis of advanced stages of colorectal carcinoma and prognosis. Serum CEA level was significantly reduced after surgery in all cases of stage Band stage C. So it indicates that surgery is main option of treatment for colorectal carcinoma.
As steady increase in S. CEA level indicate the evidence of tumor recurrence16, where as decreasing the level after operation indicate removal of tumor successfully but stable CEA level after treatment indicate failure of treatment. Regular postoperative follow up of S. CEA level is important to detect recurrence of the disease. So that further appropriate measure can be taken.
Recommendation
Serum CEA is an important prognostic marker for colorectal carcinoma which is significantly reduced after surgery so surgery is the mainstay of treatment for colorectal carcinoma.
